Search Result "IL-2."
Therapeutic Enhancement of IL-2 Through Molecular Design
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2171-2183
Author(s): Delanie J. Cassell, Shurjeel Choudhri, Rachel Humphrey, Robert E. Martell, Theresa Reynolds, Armen B. Shanafelt
Signal Transduction by IL-2 and its Receptors as Target in Treatment of Rheumatoid Arthritis
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 5 Issue: 1 Year: 2005 Page: 41-50
Author(s): V. I. Kozanidou, A. D. Theocharis, A. Georgiadis, P. V. Voulgari, A. A. Drosos, N. K. Karamanos
PEGylation Strategy for Improving the Pharmacokinetic and AntitumoralActivity of the IL-2 No-alpha Mutein
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 44 Year: 2023 Page: 3579-3588
Author(s):
Assessment of Signal Peptides to Optimize Interleukin 2 (IL-2) Folding and Expression
Journal: Current Proteomics
Volume: 16 Issue: 3 Year: 2019 Page: 188-198
Author(s): Narges Nazifi,Mojtaba Tahmoorespur,Mohammad Hadi Sekhavati,Alireza Haghparast,Mohammad Ali Behroozikhah
Immunological Mechanisms of Interleukin-2 (IL-2) Treatment in HIV/AIDS Disease
Journal: Current Molecular Pharmacology
Volume: 2 Issue: 1 Year: 2009 Page: 40-45
Author(s): C. Tincati, A. dArminio Monforte, G. Marchetti
IL-2 Receptor Targeted Immunomodulatory Biologics: The Past, Present, and Future
Journal: Current Immunology Reviews
Volume: 2 Issue: 2 Year: 2006 Page: 187-208
Author(s): Deanna D.H. Franke, Haval Shirwan
IL-2, IL-7 and IL-15 as Immuno-Modulators During SIV/HIV Vaccination and Treatment
Journal: Current HIV Research
Volume: 7 Issue: 1 Year: 2009 Page: 83-90
Author(s): Amanda Leone, Louis J. Picker, Donald L. Sodora
The Relation of the Viral Structure of SARS-CoV-2, High-RiskCondition, and Plasma Levels of IL-4, IL-10, and IL-15 in COVID-19Patients Compared to SARS and MERS Infections
Journal: Current Molecular Medicine
Volume: 22 Issue: 7 Year: 2022 Page: 584-593
Author(s): Sorayya Ghasemi,Kosar Abedini,Ramin Soltani,Leila Mousavizadeh
The Challenge of IL-2 Immunotherapy in HIV Disease: “No through Road” or Turning Point?
Journal: Current HIV Research
Volume: 6 Issue: 3 Year: 2008 Page: 189-199
Author(s): Giulia Marchetti, Camilla Tincati, Antonella dArminio Monforte, Andrea Gori
Risk Profiles in Type 2 Diabetes (Metabolic Syndrome): Integration of IL-10 Polymorphisms and Laboratory Parameters to Identify Vascular Damages Related Complications
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 7 Year: 2010 Page: 898-903
Author(s): G. I. Forte, G. Pilato, L. Vaccarino, M. Sanacore, G. Candore, G. Colonna Romano, R. Testa, C. Franceschi, M. Capri, M. Marra, A. R. Bonfigli, C. Caruso, L. Scola, D. Lio